Erin Pennock Foff, Chief Medical Officer at MapLight Therapeutics, sold MPLT on Jul 15, 2026
Data as of Oct 16
▼ SELL$291K7,845 shares at $37.04Erin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.
- Traded
- Jul 15, 2026
- Disclosed
- Jul 17, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MPLT since disclosure
−79.7%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund
Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$139Kdisclosed Jul 17 · filed the same day
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$721disclosed Jul 17 · filed 1 day after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$334Kdisclosed Jul 17 · filed 1 day after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$219Kdisclosed Jul 17 · filed 1 day after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$332Kdisclosed Jul 17 · filed 2 days after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$161Kdisclosed Jul 17 · filed 2 days after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$676disclosed Jul 17 · filed 2 days after the trade
- ▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$259Kdisclosed Jul 17 · filed 2 days after the trade